Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and
help to reduce other HPV-related cancers. We aimed to estimate the relative contribution (…

Background Human papillomavirus (HPV) contribution in vulvar intraepithelial lesions (VIN)
and invasive vulvar cancer (IVC) is not clearly established. This study provides novel data …

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV)
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …

… the genotype distribution of high-risk human papillomavirus (HRHPV) and its attribution to
… HPV genotyping with linear inverse probe hybridization (SPF10-PCR-LiPA) was performed …

… , high prevalence of human papillomavirus (HPV) infection in … type-specific prevalence and
attribution proportion to high-… determine the genotype distribution of HPV and attribution to …

… to weigh genotypes in the proportional attribution model by … to attribution to carcinogenic
HPV genotypes in which other/noncarcinogenic types did not dilute the proportional attribution …

… genotype-specific CIN3+ risks and genotype attribution in CIN3+ from cervical screening
samples. A key assumption is that genotype-… the method to 512 human papillomavirus (HPV)-…

… causal attribution of human papillomavirus (HPV) genotypes … of HPV infections and their
attribution to cervical disease in a … We demonstrate the challenges of attributing HPV genotypes …

… However, direct HPV genotype attribution to individual … used to study HPV genotype attribution
in cervical lesions and … (ICC), we studied genotype attribution using hrHPV type results …

Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in
invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We …